Analyses of publicly available genomics resources define FGF-2-expressing bladder carcinomas as EMT-prone, proliferative tumors with low mutation rates and high expression of CTLA-4, PD-1 and PD-L1
Crossref DOI link: https://doi.org/10.1038/sigtrans.2016.45
Published Online: 2017-03-17
Update policy: https://doi.org/10.1007/springer_crossmark_policy
McNiel, Elizabeth A
Tsichlis, Philip N
Text and Data Mining valid from 2017-03-17
Version of Record valid from 2017-03-17
Article History
Received: 3 November 2016
Revised: 16 December 2016
Accepted: 20 December 2016
First Online: 17 March 2017
Competing interests
: The authors declare no conflict of interest.